The wheel of innovation is spinning faster and faster. We've all heard of gene chip technology, new imaging machines, sophisticated self-diagnostics, tissue engineering, communication technologies and so much more. We see this in diagnostics, imaging, assistive devices and medical equipment. In this issue of Healthcare Quarterly, we offer you a sneak preview of some of the technologies that may have a tremendous influence in the near future.
Upcoming issues will look at technology uptake, investment in innovation and knowledge transfer.
ORTHO ProVue - ORTHO ProVue, developed by Ortho-Clinical
Diagnostics, a Johnson & Johnson company, is the first fully
automated gel testing system in North America. The instrument
automatically monitors quality control, reagent expiration and gel
card integrity, and can reduce transcription errors with its
bidirectional interface capabilities.
Pill Camera - A flushable camera, about the size of a
large vitamin pill, allows a close-up view of the small intestine.
It takes colour pictures at a rate of about two per second. The
battery-powered camera transmits digital images to a receiver belt
the patient wears all day. By late afternoon, the patient returns
to the hospital to give back the belt and have the images, all
50,000 or more of them, uploaded into the computer. And yes,
patients don't need to worry about returning the camera.
SonoSite Portable Ultrasound - SonoSite's 3 - pound
iLook, approved by the FDA in June, is the world's first
portable ultrasound. The key: SonoSite reduced twenty circuitboards
to one. The $12,000 device makes looking inside the body almost as
easy for doctors as checking your heartbeat.
NEEMO 7: Finding Terrestrial Solutions UnderwaterA team of NASA astronauts is heading underwater to test the capabilities of remote surgical technologies developed in Hamilton.
Dr. Mehran Anvari, director of McMaster's Centre for Minimal Access Surgery (CMAS), will guide NEEMO 7 - a mission that will focus on the demonstration and evaluation of innovative remote surgical technologies and techniques during a 10- day underwater mission taking place this October.
The astronauts, with Canadian Dave Williams as mission commander, will descend into the tropical waters off Key Largo, FL, to study how to surgically treat astronauts in space. This, in turn, could help patients living in remote regions without quick access to surgeons or hospitals.
There have been six NEEMO (NASA Extreme Environment Mission Operations) missions to date. NEEMO 7 is a joint project involving McMaster's Centre for Minimal Access Surgery located at St. Joseph's Healthcare Hamilton, the Canadian Space Agency, the U.S. National Oceanic and Atmospheric Administration and the National Aeronautics and Space Administration (NASA).
The main purpose of the October mission is to assess telerobotic surgery and telementoring, with a surgeon at the Hamilton base guiding the doctor doing surgery in the underwater station. The operations will be performed on a mock patient.
Each crew member aboard Aquarius will take part in a number of
operations, including repairing deep cuts to nerves and arteries,
kidney stone removals and procedures on draining an
Penelope - Robotic Scrub Nurse - In the OR, the scrub
nurse is responsible for dispensing surgical instruments kept on a
tray called the Mayo stand. Robotic Surgical Tech Inc., a Columbia
University spinoff enterprise, has developed Penelope™, the
robotic scrub nurse, with speech recognition, machine vision and
robotic arm path planning and targeting. It receives support from
the U.S. Army Telemedicine and Advanced Technology Research Command
Bionic Leg - Victhom, a Québecbased company, has created
the perfect leg, almost. The Bionic Leg is the first to allow
amputees to sit and stand up, to navigate stairs naturally, to walk
on slopes without having to compensate with the rest of their body.
It also reduces metabolic energy expenditure and contains sensors
connected to the amputee's body, a motor and a computer.
Lifecor Wearable Defib - Since its FDA approval in
January, the Lifecor LifeVest - the world's first wearable
defibrillator - has saved four lives. Designed for patients at high
risk for cardiac arrest, the vest detects abnormal heart rhythms by
sensing electrical activity on the chest surface. It weighs 3
pounds, but a 1.7-pound version, awaiting approval, is expected
Ozone Sterilizer - Québecbased, TSO3 has perfected a
sterilization process using ozone as a sterilizing agent. Their
first product is the 125L Ozone Sterilizer. The 125L - named after
its 125 litre/4.3 cubic foot capacity - was designed to sterilize
the new generation of surgical and diagnostic instruments made of
non-heat-resistant materials such as polymers and plastics. It
received its FDA approval in September 2003 and will be introduced
to the North American market late 2004.
In the surgical simulations involving telementoring, Anvari will use twoway telecommunication links to guide an untrained surgeon in Aquarius. Another simulation involves telerobotics and virtualreality technology, where Anvari will perform operations on a mock patient inside Aquarius.
Aquarius is an underwater habitat located 19 metres below the surface of the sea, 5.6 km off Key Largo in the Florida Keys National Marine Sanctuary. Owned by the U.S. National Oceanic and Atmospheric Administration, Aquarius is about 14 by 4 metres, with 11 cubic metres of living and laboratory space.
Some of the new surgical techniques, including robotic surgery
and robotic tele-surgery, have been developed at Hamilton's
Bell Canada is helping to make NEEMO 7 a success. It is the first to enable telerobotics over a surgical-grade network in Canada. Bell Canada has formed a strategic partnership with CSTAR (Canadian Surgical Technologies & Advanced Robotics) for developing and testing minimally invasive and robotic-assisted surgeries.
Dr. Patrick Luke, Urologist and Transplant Surgeon at London
Health Sciences Centre (LHSC), demonstrated telementoring live from
the floor of the Ontario Health Conference 2003 session to an
operating room at LHSC.
Immerge Knockout Pig - Randall Partner, University of
Missouri embryologist, and his team have developed the world's
first cloned pigs bred for human spare parts such as livers,
kidneys and hearts. The news went public early this year.
Biosteel - Spider Silk - Nexia Biotechnologies has
decided to refocus fibre development toward biopolymer sales and
specialized nano-scale fibre applications for spider silk. Spinning
of BioSteel proteins into nanometre diameter fibres has been
achieved and Nexia is now determining the product specifications
for medical and microelectronic applications. Nexia's technology
platform is transgenics, the introduction of a gene of interest
into the genetic makeup of animals to produce a protein. Nexia's
proprietary technology involves goats and the production of
proteins in the milk of transgenic goats.
PIXALERE - Pixalere is an Internetbased, wireless, wound
management system that provides faster homecare delivery and better
treatment for patients with complex wounds, particularly in remote
areas. Capital health is the first region in Alberta to pilot
Pixalere. It can securely, and wirelessly, transmit a patient's
clinical information and digital photos of the wound to consulting
nurses and doctors at their offices. Upon assessing the lesion, a
wound ostomy nurse can either recommend treatment directly to the
home care nurse or forward the image and information to a
specialist physician for further consultation.
Toronto Rehab to launch iDAPTThe Toronto Rehabilitation Institute is building one of the world's most advanced research facilities where new therapies and assistive technologies will be developed for people recovering from disabling injury or illness. The $36 million iDAPT project (Intelligent Design for Adaptation, Participation and Technology), with its high tech laboratories and unique testing facilities, will be housed at the hospital's redeveloped University Centre.
Led by Dr. Geoff Fernie, Toronto Rehab's VP of Research, in collaboration with academic centres across Canada, the iDAPT project is the country's single largest rehabilitation research initiative. Funding for the first phase of the project has been provided, in part, by the Canada Foundation for Innovation with matching funds through the Ontario Innovation Trust.
A funding proposal for phase II of the iDAPT project, to build
working spaces for up to 200 scientists and additional
laboratories, is currently under review.
Rendering #1 - The Challenging Environment Assessment Laboratory
(CEAL), part of phase I of the iDAPT project will be built 60 feet
below ground at Toronto Rehab's redeveloped University Centre. CEAL
will simulate diverse environmental situations such as winter
conditions, unstable walking terrains, and a variety of other
challenging environments and conditions enabling scientists to
develop new and practical solutions to the real life obstacles
people with disabilities encounter.
Rendering #2 - The Home Environment Laboratory (foreground) and
the Institutional Environment Laboratory (far corner) are part of
phase II of the iDAPT project and will be located on the top floor
of Toronto Rehab's new patient care tower. Research here will focus
on the development of artificial intelligence and smart home
technologies designed to help people with disabilities to live as
independently as possible and to improve their quality of
Rendering #3 - The Innovations Gallery and Participant Recruitment Centre, another facility stemming from phase II of the project, will be located on the hospital's second floor. Prototypes and products developed by iDAPT's team of scientists, engineers and industrial designers will be showcased here. Information about research projects will also be available, and research study recruitment will take place.
Be the first to comment on this!
Personal Subscriber? Sign In
Note: Please enter a display name. Your email address will not be publically displayed